During the past decade, Spitalul Clinic Judetean de Urgenta Timisoara conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 12 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalul Clinic Judetean de Urgenta Timisoara" #1 sponsor was "Celgene" with 6 trials, followed by "Pfizer" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Actelion" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalul Clinic Judetean de Urgenta Timisoara" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Spitalul Clinic Judetean de Urgenta Timisoara" are "Multiple Sclerosis" (4 trials), "Relapsing Multiple Sclerosis" (2 trials), "Ulcerative Colitis" (2 trials), "Acromegaly" (1 trials) and "Acute Respiratory Distress Syndrome" (1 trials). Many other conditions were trialed in "Spitalul Clinic Judetean de Urgenta Timisoara" in a lesser frequency.

Most popular intervention types in "Spitalul Clinic Judetean de Urgenta Timisoara" are "Drug" (27 trials), "Other" (3 trials), "Combination Product" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Ozanimod" (3 trials), "RPC1063" (3 trials), "ATM-AVI" (2 trials) and "Interferon beta-1a" (2 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Clinic Judetean de Urgenta Timisoara" are 30 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Spitalul Clinic Judetean de Urgenta Timisoara". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Spitalul Clinic Judetean de Urgenta Timisoara, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Clinic Judetean de Urgenta Timisoara, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".